Filing Details
- Accession Number:
- 0001225208-13-017527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-08 16:44:44
- Reporting Period:
- 2013-08-07
- Filing Date:
- 2013-08-08
- Accepted Time:
- 2013-08-08 16:44:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1273239 | Jr G Richard Brown | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Vice President And Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-08-07 | 11,067 | $31.16 | 66,008 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-08-07 | 10,960 | $39.32 | 76,968 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-08-07 | 9,389 | $39.18 | 86,357 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-08-07 | 7,956 | $43.44 | 94,313 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-08-07 | 3,649 | $42.39 | 97,962 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-08-07 | 31,697 | $63.43 | 66,265 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-07 | 10,960 | $0.00 | 10,960 | $39.32 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-07 | 7,956 | $0.00 | 7,956 | $43.44 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-07 | 9,389 | $0.00 | 9,389 | $39.18 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-07 | 3,649 | $0.00 | 3,649 | $42.39 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-07 | 11,067 | $0.00 | 11,067 | $31.16 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-07-02 | No | 4 | M | Direct | |
3,979 | 2019-11-30 | No | 4 | M | Direct | |
9,390 | 2020-11-30 | No | 4 | M | Direct | |
10,949 | 2021-11-30 | No | 4 | M | Direct | |
0 | 2018-12-01 | No | 4 | M | Direct |
Footnotes
- Includes unvested restricted stock units and associated unvested dividend equivalent units, the number of which were adjusted in connection with the recent spin-off of Covidien's pharmaceuticals business. Also includes 657 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $63.4000 to $63.5150. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.